Ticker Symbol: QNRX
Quoin Pharmaceuticals Ltd - ADR
$5.67 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Israel
Currency:
USD
Asset
Type: ADR
CIK:0001671502
Company Profile
Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
Website: cellect.co
CEO: Shai Yarkoni
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $4.25
Change:
-$0.01
(
-0.24%)
Days Range: $4.20 - $4.50
Beta: 1.38
52wk. High: $406.08
52wk. Low: $3.66
Ytd. Change -98.15%
50 Day Moving Average: $4.75
200 Day Moving Average: $38.49
Shares Outstanding: 1820
Valuation
Market Cap: $7,735.00
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A